2,717 results on '"Folkert J"'
Search Results
2. Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands
- Author
-
Tessa M. Schurink‐van ’t Klooster, Albert G. Siebers, Joske Hoes, Folkert J. vanKemenade, Johannes Berkhof, Johannes A. Bogaards, and Hester E. deMelker
- Subjects
bivalent HPV‐vaccine ,cytological cervical abnormalities ,high‐grade cervical lesions ,high‐risk HPV ,HSIL ,human papillomavirus ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background The first HPV‐vaccine eligible cohorts in the Netherlands will enter the cervical screening program in 2023. However, a substantial number of young women already have had a cervical sample taken before entry into the regular screening program. This study was initiated to explore early effects of HPV vaccination on detection of cytological abnormalities in cervical samples of women younger than the screening age. Methods Results of cervical samples were obtained from the Dutch National Pathology Databank (PALGA) and were linked to the women's HPV vaccination status from the national vaccination registry (Praeventis) (N = 42,171). Occurrence of low‐grade and high‐grade squamous intraepithelial lesions or worse (LSIL and HSIL+) and high‐risk HPV positive tests (hrHPV) in the first cervical sample were compared between vaccinated and unvaccinated women by multivariable logistic regression analysis, corrected for age at cervical sampling and age of vaccination (12/13 years, ≥ = 14 years). Results For fully vaccinated women (three‐ or two‐dose schedule), statistically significant reductions were seen for all outcomes compared to unvaccinated women (hrHPV: adjusted OR, 0.70, 95% CI, 0.63–0.79; LSIL: 0.70, 0.61–0.80; HSIL+: 0.39, 0.30–0.51). Conclusions By linking nation‐wide registries on pathology and vaccination, we show significant beneficial early effects of HPV‐vaccination on LSIL, HSIL+, CIN3/AIS/carcinoma and hrHPV detection in young women upto 24 years of age who have a cervical sample taken before entry into the cervical cancer screening program.
- Published
- 2023
- Full Text
- View/download PDF
3. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT)
- Author
-
Emilie C. H. Breekveldt, Esther Toes-Zoutendijk, Lucie de Jonge, Manon C. W. Spaander, Evelien Dekker, Folkert J. van Kemenade, Anneke J. van Vuuren, Christian R. B. Ramakers, Iris D. Nagtegaal, Monique E. van Leerdam, and Iris Lansdorp-Vogelaar
- Subjects
Colorectal cancer ,Colorectal neoplasia ,Colonoscopy ,Colorectal cancer screening ,Fecal immunochemical testing ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Abstract Background In 2014, the national population-based colorectal cancer (CRC) screening program was implemented in the Netherlands. Biennial fecal immunochemical testing (FIT) for hemoglobin (Hb) is used at a cut-off of 47 µg Hb per gram feces. The CRC screening program successfully started, with high participation rates and yield of screening. Now that the program has reached a steady state, there is potential to further optimize the program. Previous studies showed that prior fecal Hb (f-Hb) concentrations just below the FIT cut-off are associated with a higher risk for detection of advanced neoplasia (AN) at subsequent screening rounds. We aim to achieve a better balance between the harms and benefits of CRC screening by offering participants tailored invitation intervals based on prior f-Hb concentrations after negative FIT. Methods This mixed-methods study will be performed within the Dutch national CRC screening program and will consist of: (1) a randomized controlled trial (RCT), (2) focus group studies, and (3) decision modelling. The primary outcome is the yield of AN per screened individual in personalized screening vs. uniform screening. Secondary outcomes are perspectives on, acceptability of and adherence to personalized screening, as well as long-term outcomes of personalized vs. uniform screening. The RCT will include 20,000 participants of the Dutch CRC screening program; 10,000 in the intervention and 10,000 in the control arm. The intervention arm will receive a personalized screening interval based on the prior f-Hb concentration (1, 2 or 3 years). The control arm will receive a screening interval according to current practice (2 years). The focus group studies are designed to understand individuals’ perspectives on and acceptability of personalized CRC screening. Results of the RCT will be incorporated into the MISCAN-Colon model to determine long-term benefits, harms, and costs of personalized vs. uniform CRC screening. Discussion The aim of this study is to evaluate the yield, feasibility, acceptability and (cost-) effectiveness of personalized CRC screening through tailored invitation intervals based on prior f-Hb concentrations. This knowledge may be of guidance for health policy makers and may provide evidence for implementing personalized CRC screening in The Netherlands and/or other countries using FIT as screening modality. Trial registration: ClinicalTrials.gov, NCT05423886, June 21, 2022, https://clinicaltrials.gov/ct2/show/NCT05423886
- Published
- 2023
- Full Text
- View/download PDF
4. The yeast RNA methylation complex consists of conserved yet reconfigured components with m6A-dependent and independent roles
- Author
-
Imke Ensinck, Alexander Maman, Waleed S Albihlal, Michelangelo Lassandro, Giulia Salzano, Theodora Sideri, Steven A Howell, Enrica Calvani, Harshil Patel, Guy Bushkin, Markus Ralser, Ambrosius P Snijders, Mark Skehel, Ana Casañal, Schraga Schwartz, and Folkert J van Werven
- Subjects
N6-methyladenosine ,methyltransferase complex ,m6A ,MTC ,Ime4 ,Vir1 ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
N6-methyladenosine (m6A), the most abundant mRNA modification, is deposited in mammals/insects/plants by m6A methyltransferase complexes (MTC) comprising a catalytic subunit and at least five additional proteins. The yeast MTC is critical for meiosis and was known to comprise three proteins, of which two were conserved. We uncover three novel MTC components (Kar4/Ygl036w-Vir1/Dyn2). All MTC subunits, except for Dyn2, are essential for m6A deposition and have corresponding mammalian MTC orthologues. Unlike the mammalian bipartite MTC, the yeast MTC is unipartite, yet multifunctional. The mRNA interacting module, comprising Ime4, Mum2, Vir1, and Kar4, exerts the MTC’s m6A-independent function, while Slz1 enables the MTC catalytic function in m6A deposition. Both functions are critical for meiotic progression. Kar4 also has a mechanistically separate role from the MTC during mating. The yeast MTC constituents play distinguishable m6A-dependent, MTC-dependent, and MTC-independent functions, highlighting their complexity and paving the path towards dissecting multi-layered MTC functions in mammals.
- Published
- 2023
- Full Text
- View/download PDF
5. Identification of over- and undertreatment in the Dutch national cervical cancer screening program: A data linkage study at the hospital level
- Author
-
Maarten D. Vink, Geeske Hofstra, Xander Koolman, Ruud L. Bekkers, Albert G. Siebers, Folkert J. van Kemenade, Koen B. Böcker, Michiel ten Hove, and Eric J. van der Hijden
- Subjects
Cervical intraepithelial neoplasia ,Quality indicators ,Guideline adherence ,Cervical cancer screening ,National screening program ,Health policy ,Medicine - Abstract
Research into the quality of cancer screening programs often lacks the perspective of clinicians, missing insights into the performance of individual hospitals. This retrospective cohort study aimed to identify guideline deviation (specifically, overtreatment and undertreatment) related to the cervical cancer screening program in Dutch hospitals by deterministically linking nationwide insurance data with pathology data for cervical intraepithelial neoplasia (CIN). We then constructed quality indicators using the Dutch CIN guideline and National Health Care Institute recommendations to assess compliance with CIN management, treatment outcomes, and follow-up, using an empirical Bayes shrinkage model to correct for case-mix variation and hospitals with few observations. Data were linked for 115,899 of 125,751 (92%) eligible women. Overtreatment was observed in the see-and-treat approach (immediate treatment) for women with low-grade referral cytology (4%; hospital range, 0%–25%), CIN ≤ 1 treatment specimens (26%; hospital range, 10%–55%), and follow-up cervix cytology ≥2 months before the guideline recommendation after treatment for CIN 2 (2%; hospital range, 0%–9%) or CIN 3 (5%; hospital range, 0%–19%). By contrast, undertreatment was observed for treatment within 3 months after a CIN 3 biopsy result (90%; hospital range 59%–100%) and follow-up ≥2 months beyond the guideline recommendation after treatments for CIN 2 (21%, hospital range 7%–48%) and CIN 3 (20%, hospital range 7%–90%). In conclusion, we found evidence of CIN overtreatment and undertreatment in all measured domains at the hospital level. Guideline adherence could be improved by implementing the developed indicators in an audit and feedback instrument for use by healthcare professionals in routine practice.
- Published
- 2023
- Full Text
- View/download PDF
6. The Role of the IGF2 Methylation Score in Diagnosing Adrenocortical Tumors with Unclear Malignant Potential—Feasibility of Formalin-Fixed Paraffin-Embedded Tissue
- Author
-
Rebecca V. Steenaard, Richard A. Feelders, Fadime Dogan, Peter M. van Koetsveld, Sara G. Creemers, Madeleine H. T. Ettaieb, Folkert J. van Kemenade, Harm R. Haak, and Leo J. Hofland
- Subjects
adrenocortical carcinoma ,adrenocortical adenoma ,IGF2 ,methylation ,formalin-fixed paraffin-embedded tissue ,Biology (General) ,QH301-705.5 - Abstract
The differentiation between benign and malignant adrenocortical tumors based on pathological assessment can be difficult. We present a series of 17 patients with unclear malignant tumors, of whom six had recurrent or metastatic disease. The assessment of the methylation pattern of insulin-like growth factor 2 (IGF2) regulatory regions in fresh frozen material has shown to be valuable in determining the malignancy of adrenocortical tumors, although this has not been elaborately tested in unclear malignant tumors. Since fresh frozen tissue was only available in six of the patients, we determined the feasibility of using formalin-fixed paraffin-embedded (FFPE) tissue for this method. We isolated DNA from FFPE tissue and matched the fresh frozen tissue of three patients with adrenocortical carcinoma. Methylation patterns of IGF2 regulatory regions were determined by pyrosequencing using different amounts of bisulfite-converted DNA (5 ng, 20 ng, 40 ng). Compared to fresh frozen tissue, FFPE tissue had a higher failure rate (fresh frozen 0%; FFPE 18.5%) and poor-to-moderate replicability (fresh frozen rho = 0.89–0.99, median variation 1.6%; FFPE rho = −0.09–0.85, median variation 7.7%). There was only a poor-to-moderate correlation between results from fresh frozen and FFPE tissue (rho = −0.28–0.70, median variation 13.2%). In conclusion, FFPE tissue is not suitable for determining the IGF2 methylation score in patients with an unclear malignant adrenocortical tumor using the currently used method. We, therefore, recommend fresh frozen storage of resection material for diagnostic and biobank purposes.
- Published
- 2023
- Full Text
- View/download PDF
7. RNA modifications detection by comparative Nanopore direct RNA sequencing
- Author
-
Adrien Leger, Paulo P. Amaral, Luca Pandolfini, Charlotte Capitanchik, Federica Capraro, Valentina Miano, Valentina Migliori, Patrick Toolan-Kerr, Theodora Sideri, Anton J. Enright, Konstantinos Tzelepis, Folkert J. van Werven, Nicholas M. Luscombe, Isaia Barbieri, Jernej Ule, Tomas Fitzgerald, Ewan Birney, Tommaso Leonardi, and Tony Kouzarides
- Subjects
Science - Abstract
Nanopore direct RNA Sequencing data contain information about the presence of RNA modifications, but their detection poses substantial challenges. Here the authors introduce Nanocompore, a new methodology for modification detection from Nanopore data.
- Published
- 2021
- Full Text
- View/download PDF
8. N6-methyladenosine (m6A) reader Pho92 is recruited co-transcriptionally and couples translation to mRNA decay to promote meiotic fitness in yeast
- Author
-
Radhika A Varier, Theodora Sideri, Charlotte Capitanchik, Zornitsa Manova, Enrica Calvani, Alice Rossi, Raghu R Edupuganti, Imke Ensinck, Vincent WC Chan, Harshil Patel, Joanna Kirkpatrick, Peter Faull, Ambrosius P Snijders, Michiel Vermeulen, Markus Ralser, Jernej Ule, Nicholas M Luscombe, and Folkert J van Werven
- Subjects
m6A ,RNA decay ,Pho92 ,YTH ,meiosis ,translation ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
N6- methyladenosine (m6A) RNA modification impacts mRNA fate primarily via reader proteins, which dictate processes in development, stress, and disease. Yet little is known about m6A function in Saccharomyces cerevisiae, which occurs solely during early meiosis. Here, we perform a multifaceted analysis of the m6A reader protein Pho92/Mrb1. Cross-linking immunoprecipitation analysis reveals that Pho92 associates with the 3’end of meiotic mRNAs in both an m6A-dependent and independent manner. Within cells, Pho92 transitions from the nucleus to the cytoplasm, and associates with translating ribosomes. In the nucleus Pho92 associates with target loci through its interaction with transcriptional elongator Paf1C. Functionally, we show that Pho92 promotes and links protein synthesis to mRNA decay. As such, the Pho92-mediated m6A-mRNA decay is contingent on active translation and the CCR4-NOT complex. We propose that the m6A reader Pho92 is loaded co-transcriptionally to facilitate protein synthesis and subsequent decay of m6A modified transcripts, and thereby promotes meiosis.
- Published
- 2022
- Full Text
- View/download PDF
9. High-resolution analysis of cell-state transitions in yeast suggests widespread transcriptional tuning by alternative starts
- Author
-
Minghao Chia, Cai Li, Sueli Marques, Vicente Pelechano, Nicholas M. Luscombe, and Folkert J. van Werven
- Subjects
Biology (General) ,QH301-705.5 ,Genetics ,QH426-470 - Abstract
Abstract Background The start and end sites of messenger RNAs (TSSs and TESs) are highly regulated, often in a cell-type-specific manner. Yet the contribution of transcript diversity in regulating gene expression remains largely elusive. We perform an integrative analysis of multiple highly synchronized cell-fate transitions and quantitative genomic techniques in Saccharomyces cerevisiae to identify regulatory functions associated with transcribing alternative isoforms. Results Cell-fate transitions feature widespread elevated expression of alternative TSS and, to a lesser degree, TES usage. These dynamically regulated alternative TSSs are located mostly upstream of canonical TSSs, but also within gene bodies possibly encoding for protein isoforms. Increased upstream alternative TSS usage is linked to various effects on canonical TSS levels, which range from co-activation to repression. We identified two key features linked to these outcomes: an interplay between alternative and canonical promoter strengths, and distance between alternative and canonical TSSs. These two regulatory properties give a plausible explanation of how locally transcribed alternative TSSs control gene transcription. Additionally, we find that specific chromatin modifiers Set2, Set3, and FACT play an important role in mediating gene repression via alternative TSSs, further supporting that the act of upstream transcription drives the local changes in gene transcription. Conclusions The integrative analysis of multiple cell-fate transitions suggests the presence of a regulatory control system of alternative TSSs that is important for dynamic tuning of gene expression. Our work provides a framework for understanding how TSS heterogeneity governs eukaryotic gene expression, particularly during cell-fate changes.
- Published
- 2021
- Full Text
- View/download PDF
10. Long undecoded transcript isoform (LUTI) detection in meiotic budding yeast by direct RNA and transcript leader sequencing
- Author
-
Amy Tresenrider, Minghao Chia, Folkert J. van Werven, and Elçin Ünal
- Subjects
Bioinformatics ,Sequence analysis ,Genetics ,Genomics ,Sequencing ,Model Organisms ,Science (General) ,Q1-390 - Abstract
Summary: LUTIs (Long Undecoded Transcript Isoforms) are 5′-extended and poorly translated mRNAs that can downregulate transcription from promoters more proximal to a gene’s coding sequence (CDS). In this protocol, polyA RNA is extracted from budding yeast cells undergoing highly synchronized meiosis. Using a combination of long-read direct RNA sequencing and transcript leader sequencing (TL-seq), meiosis-specific LUTIs are systematically identified. Following identification, TL-seq is used to quantify the abundance of both LUTI and the more canonical gene-proximal (PROX) transcripts.For complete details on the use and execution of this protocol, please refer to Tresenrider et al. (2021).
- Published
- 2022
- Full Text
- View/download PDF
11. Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
- Author
-
Lucie de Jonge, Hilliene J van de Schootbrugge-Vandermeer, Emilie C H Breekveldt, Manon C W Spaander, Hanneke J van Vuuren, Folkert J van Kemenade, Evelien Dekker, Iris D Nagtegaal, Monique E van Leerdam, and Iris Lansdorp-Vogelaar
- Subjects
Medicine ,Science - Abstract
ObjectiveThe COVID-19 pandemic forced colorectal cancer (CRC) screening programs to downscale their colonoscopy capacity. In this study, we assessed strategies to deal with temporary restricted colonoscopy capacity in a FIT-based CRC screening program while aiming to retain the maximum possible preventive effect of the screening program.DesignWe simulated the Dutch national CRC screening program inviting individuals between ages 55 and 75 for biennial FIT using the MISCAN-Colon model including the 3-month disruption in the first half of 2020 due to the COVID-19 pandemic. For the second half of 2020 and 2021, we simulated three different strategies for the total target population: 1) increasing the FIT cut-off, 2) skipping one screening for specific screening ages, and 3) extending the screening interval. We estimated the impact on required colonoscopy capacity in 2020-2021 and life years (LYs) lost in the long-term.ResultsIncreasing the FIT cut-off, skipping screening ages and extending the screening interval resulted in a maximum reduction of 25,100 (-17.0%), 16,100(-10.9%) and 19,000 (-12.9%) colonoscopies, respectively. Modelling an increased FIT cut-off, the number of LYs lost ranged between 1,400 and 4,400. Skipping just a single screening age resulted in approximately 2,700 LYs lost and this was doubled in case of skipping two screening ages. Extending the screening interval up to 34 months had the smallest impact on LYs lost (up to 1,100 LYs lost).ConclusionThis modelling study shows that to anticipate on restricted colonoscopy capacity, temporarily extending the screening interval retains the maximum possible preventive effect of the CRC screening program.
- Published
- 2022
- Full Text
- View/download PDF
12. Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing
- Author
-
Miriam P. van der Meulen, Esther Toes-Zoutendijk, Manon C. W. Spaander, Evelien Dekker, Johannes M. G. Bonfrer, Anneke J. van Vuuren, Ernst J. Kuipers, Folkert J. van Kemenade, M. F. van Velthuysen, Maarten G. J. Thomeer, Harriët van Veldhuizen, Harry J. de Koning, Iris Lansdorp-Vogelaar, and Monique E. van Leerdam
- Subjects
Medicine ,Science - Abstract
Background CRC mortality rates are higher for individuals with a lower socioeconomic status (SES). Screening could influence health inequalities. We therefore aimed to investigate SES differences in participation and diagnostic yield of FIT screening. Methods All invitees in 2014 and 2015 in the Dutch national CRC screening programme were included in the analyses. We used area SES as a measure for SES and divided invitees into quintiles, with Quintile 1 being the highest SES. Logistic regression analysis was used to compare the participation rate, positivity rate, colonoscopy uptake, positive predictive value (PPV) and detection rate across the SES groups. Results Participation to FIT screening was significantly lower for Quintile 5 (67.0%) compared to the other Quintiles (73.0% to 75.1%; adjusted OR quintile 5 versus quintile 1: 0.73, 95%CI: 0.72–0.74), as well as colonoscopy uptake after a positive FIT (adjusted OR 0.73, 95%CI: 0.69–0.77). The detection rate per FIT participant for advanced neoplasia gradually increased from 3.3% in Quintile 1 to 4.0% in Quintile 5 (adjusted OR 1.20%, 95%CI 1.16–1.24). As a result of lower participation, the yield per invitee was similar for Quintile 5 (2.04%) and Quintile 1 (2.00%), both being lower than Quintiles 2 to 4 (2.20%-2.28%). Conclusions Screening has the potential to reduce health inequalities in CRC mortality, because of a higher detection in participants with a lower SES. However, in the Dutch screening programme, this is currently offset by the lower participation in this group.
- Published
- 2022
13. Regulated repression governs the cell fate promoter controlling yeast meiosis
- Author
-
Janis Tam and Folkert J. van Werven
- Subjects
Science - Abstract
In budding yeast, the decision to enter meiosis is defined by nutrient and mating-type signals regulating expression of the master transcription factor for meiotic entry, IME1. Here, the authors characterize the steps involved in regulating the entering in meiosis via the co-repressor complex Tup1-Cyc8.
- Published
- 2020
- Full Text
- View/download PDF
14. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124‐2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions
- Author
-
Annemiek Leeman, David Jenkins, Marta delPino, Jaume Ordi, Aureli Torné, John Doorbar, Chris J. L. M. Meijer, Folkert J. vanKemenade, and Wim G. V. Quint
- Subjects
cervical cancer ,hrHPV ,immunohistochemistry ,LEEP ,methylation ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract The decision to treat a cervical squamous intraepithelial lesion (SIL) by loop electrosurgical excision procedure (LEEP) relies heavily on a colposcopy‐directed biopsy showing high‐grade (H)SIL. Diagnosis is often supported by p16, an immunohistochemical (IHC) biomarker of high‐risk (hr)HPV E7 gene activity. Additional potential markers include methylation of tumor suppressor genes FAM19A4/miR124‐2 in cervical cytology for advanced transforming HSIL and the IHC marker HPV E4 for productive, potentially regressing lesions. In 318 women referred for colposcopy, we investigated the relationship between staining patterns of p16 and E4 IHC in the worst biopsy, and the relation of these to FAM19A4/miR124‐2 methylation status in cytology. E4‐positive staining decreased with increasing SIL/CIN grade from 41% in LSIL to 3% in HSIL/CIN3. E4 positivity increased with grade of p16 when p16 expression was limited to the lower two third of the epithelium (r = 0.378), but fell with expression over. Loss of E4 expression in the worst lesion was associated with the methylation of FAM19A4/miR124‐2. We also examined whether these biomarkers can predict the histological outcome of the LEEP biopsy in a subgroup of 119 who underwent LEEP treatment. About 85% of women with ≥lower two third p16 staining/E4‐negative HSIL biopsies and 65% with limited p16 staining/E4‐positive HSIL biopsies had ≥HSIL in the LEEP specimen (P = .025). p16 expression in a biopsy is related both to viral production and transformation, while decreased E4 expression relates to methylation, indicating advanced HSIL. p16 expression in ≥2/3 of the epithelium and absent E4 indicate likely HSIL on a subsequent LEEP specimen.
- Published
- 2020
- Full Text
- View/download PDF
15. Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
- Author
-
Clare A. Aitken, Heleen M. E. van Agt, Albert G. Siebers, Folkert J. van Kemenade, Hubert G. M. Niesters, Willem J. G. Melchers, Judith E. M. Vedder, Rob Schuurman, Adriaan J. C. van den Brule, Hans C. van der Linden, John W. J. Hinrichs, Anco Molijn, Klaas J. Hoogduin, Bettien M. van Hemel, and Inge M. C. M. de Kok
- Subjects
Cervical cancer screening ,hrHPV screening ,Population-based screening ,Cancer screening programmes ,Medicine - Abstract
Abstract Background In January 2017, the Dutch cervical cancer screening programme transitioned from cytomorphological to primary high-risk HPV (hrHPV) DNA screening, including the introduction of self-sampling, for women aged between 30 and 60 years. The Netherlands was the first country to switch to hrHPV screening at the national level. We investigated the health impact of this transition by comparing performance indicators from the new hrHPV-based programme with the previous cytology-based programme. Methods We obtained data from the Dutch nationwide network and registry of histo- and cytopathology (PALGA) for 454,573 women eligible for screening in 2017 who participated in the hrHPV-based programme between 1 January 2017 and 30 June 2018 (maximum follow-up of almost 21 months) and for 483,146 women eligible for screening in 2015 who participated in the cytology-based programme between 1 January 2015 and 31 March 2016 (maximum follow-up of 40 months). We compared indicators of participation (participation rate), referral (screen positivity; referral rate) and detection (cervical intraepithelial neoplasia (CIN) detection; number of referrals per detected CIN lesion). Results Participation in the hrHPV-based programme was significantly lower than that in the cytology-based programme (61% vs 64%). Screen positivity and direct referral rates were significantly higher in the hrHPV-based programme (positivity rate: 5% vs 9%; referral rate: 1% vs 3%). CIN2+ detection increased from 11 to 14 per 1000 women screened. Overall, approximately 2.2 times more clinical irrelevant findings (i.e. ≤CIN1) were found in the hrHPV-based programme, compared with approximately 1·3 times more clinically relevant findings (i.e. CIN2+); this difference was mostly due to a national policy change recommending colposcopy, rather than observation, of hrHPV-positive, ASC-US/LSIL results in the hrHPV-based programme. Conclusions This is the first time that comprehensive results of nationwide implementation of hrHPV-based screening have been reported using high-quality data with a long follow-up. We have shown that both benefits and potential harms are higher in one screening round of a well-implemented hrHPV-based screening programme than in an established cytology-based programme. Lower participation in the new hrHPV programme may be due to factors such as invitation policy changes and the phased roll-out of the new programme. Our findings add further to evidence from trials and modelling studies on the effectiveness of hrHPV-based screening.
- Published
- 2019
- Full Text
- View/download PDF
16. Cryo-Gel embedding compound for renal biopsy biobanking
- Author
-
Malou L. H. Snijders, Marina Zajec, Laurens A. J. Walter, Remco M. A. A. de Louw, Monique H. A. Oomen, Shazia Arshad, Thierry P. P. van den Bosch, Lennard J. M. Dekker, Michail Doukas, Theo M. Luider, Peter H. J. Riegman, Folkert J. van Kemenade, and Marian C. Clahsen-van Groningen
- Subjects
Medicine ,Science - Abstract
Abstract Optimal preservation and biobanking of renal tissue is vital for good diagnostics and subsequent research. Optimal cutting temperature (OCT) compound is a commonly used embedding medium for freezing tissue samples. However, due to interfering polymers in OCT, analysis as mass spectrometry (MS) is difficult. We investigated if the replacement of OCT with Cryo-Gel as embedding compound for renal biopsies would enable proteomics and not disturb other common techniques used in tissue diagnostics and research. For the present study, fresh renal samples were snap-frozen using Cryo-Gel, OCT and without embedding compound and evaluated using different techniques. In addition, tissue samples from normal spleen, skin, liver and colon were analyzed. Cryo-Gel embedded tissues showed good morphological preservation and no interference in immunohistochemical or immunofluorescent investigations. The quality of extracted RNA and DNA was good. The number of proteins identified using MS was similar between Cryo-Gel embedded samples, samples without embedding compound and OCT embedded samples. However, polymers in the OCT disturbed the signal in the MS, while this was not observed in the Cryo-Gel embedded samples. We conclude that embedding of renal biopsies in Cryo-Gel is an excellent and preferable alternative for OCT compound for both diagnostic and research purposes, especially in those cases where proteomic analysis might be necessary.
- Published
- 2019
- Full Text
- View/download PDF
17. Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
- Author
-
Federica Inturrisi, Clare A. Aitken, Willem J.G. Melchers, Adriaan J.C. van den Brule, Anco Molijn, John W.J. Hinrichs, Hubert G.M. Niesters, Albert G. Siebers, Rob Schuurman, Daniëlle A.M. Heideman, Inge M.C.M. de Kok, Ruud L.M. Bekkers, Folkert J. van Kemenade, and Johannes Berkhof
- Subjects
Human papillomavirus (HPV) ,Cervical intraepithelial neoplasia ,CIN3 ,Self-sampling ,Cervical screening ,Clinical accuracy ,Public aspects of medicine ,RA1-1270 - Abstract
Background: High-risk human papillomavirus (hrHPV) testing on self-collected samples has potential as a primary screening tool in cervical screening, but real-world evidence on its accuracy in hrHPV-based screening programmes is lacking. Methods: In the Netherlands, women aged 30–60 years invited for cervical screening can choose between sampling at the clinician's office (Cervex Brush) or self-sampling at home (Evalyn Brush). HrHPV testing is performed using Roche Cobas 4800. We collected screening test results between January 2017 and March 2018 and histological follow-up until August 2019. The main outcome measures were mean cycle threshold (Ct) value, cervical intraepithelial neoplasia (CIN) grade 3 or cancer (CIN3+) and CIN grade 2 or worse (CIN2+). Findings: 30,808 women had a self-collected and 456,207 had a clinician-collected sample. In hrHPV-positive women with adequate cytology, Ct values were higher for self-collection than clinician-collection with a mean Ct difference of 1·25 (95% CI 0·98–1·52) in women without CIN2+, 2·73 (1·75–3·72) in CIN2 and 3·59 (3·03–4·15) in CIN3+. The relative sensitivity for detecting CIN3+ was 0·94 (0·90–0·97) for self-collection versus clinician-collection and the relative specificity was 1·02 (1·02–1·02). Interpretation: The clinical accuracy of hrHPV testing on a self-collected sample for detection of CIN3+ is high and supports its use as a primary screening test for all invited women. Because of the slightly lower sensitivity of hrHPV testing on a self-collected compared to a clinician-collected sample, an evaluation of the workflow procedure to optimise clinical performance seems warranted. Funding: National Institute for Public Health and the Environment (the Netherlands) and the European Commission.
- Published
- 2021
- Full Text
- View/download PDF
18. Investigating the decrease in participation in the Dutch cervical cancer screening programme: The role of personal and organisational characteristics
- Author
-
Clare A. Aitken, Sylvia Kaljouw, Albert G. Siebers, Matilde Bron, Anne Morssink, Folkert J. van Kemenade, and Inge M.C.M. de Kok
- Subjects
Cervical cancer screening ,Screening attendance ,Organised screening ,Medicine - Abstract
Declining attendance in the Dutch cervical cancer screening programme was recently observed, coinciding with preparations for implementing primary hrHPV-based screening, which was implemented in January 2017. We aimed to investigate which factors were related to decreased attendance. We conducted a population-based cohort study including all women aged 30 to 60 years who were eligible for screening between 2014 and 2018. Attendance was defined as participation in the screening programme within 15 months of the start of the invitation-eligible year. We used data from the Dutch pathology archive (PALGA) linked with data from Statistics Netherlands to investigate population characteristics (position in the household, household income, socio-economic status, number of people in the household, migration background, age) and data from the five Dutch screening organisations (SO) to investigate the effect of cessing self-inviting GP’s (‘inviting organisation’). SO’s were termed SO 1 to 5. Higher attendance rates were observed in women who were employed (60.8%), married (62.9%), Dutch (61.2%), in the highest income bracket (63.4%), living in households with four persons (65.3%) and women who were invited by their GP (69.8%). Differences in personal characteristics did not explain the decline in attendance rates. By adjusting for whether the GP or the SO sent the invitation, the differences in attendance rates between 2014 and 2015 and 2016 and between 2014 and 2015 and 2017–2018 were explained in some screening organisations. Removing the possibility for GPs to send invitations explains some of the decline in participation, although this did not account for the total change in attendance.
- Published
- 2021
- Full Text
- View/download PDF
19. Cervical intraepithelial neoplasia and the risk of spontaneous preterm birth: A Dutch population-based cohort study with 45,259 pregnancy outcomes.
- Author
-
Diede L Loopik, Joris van Drongelen, Ruud L M Bekkers, Quirinus J M Voorham, Willem J G Melchers, Leon F A G Massuger, Folkert J van Kemenade, and Albert G Siebers
- Subjects
Medicine - Abstract
BackgroundExcisional procedures of cervical intraepithelial neoplasia (CIN) may increase the risk of preterm birth. It is unknown whether this increased risk is due to the excision procedure itself, to the underlying CIN, or to secondary risk factors that are associated with both preterm birth and CIN. The aim of this study is to assess the risk of spontaneous preterm birth in women with treated and untreated CIN and examine possible associations by making a distinction between the excised volume of cervical tissue and having cervical disease.Methods and findingsThis Dutch population-based observational cohort study identified women aged 29 to 41 years with CIN between 2005 and 2015 from the Dutch pathology registry (PALGA) and frequency matched them with a control group without any cervical abnormality based on age at and year of pathology outcome (i.e., CIN or normal cytology) and urbanization (ConclusionsIn this study, we observed a strong correlation between preterm birth and a volume of ≥0.5 cc excised cervical tissue, regardless of the severity of CIN. Caution should be taken when performing excisional treatment in women of reproductive age as well as prudence in case of multiple biopsies. Fertile women with a history of performing multiple biopsies or excisional treatment for CIN may benefit from close surveillance during pregnancy.
- Published
- 2021
- Full Text
- View/download PDF
20. Microbubble Enhanced Echocardiography in Current Cardiology Practice
- Author
-
Mihai Strachinaru and Folkert J ten Cate
- Subjects
microbubble enhanced echocardiography ,ultrasound enhancing agents ,contrast-enhanced ultrasound ,contrast echocardiography ,safety ,review ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Contrast-enhanced ultrasound imaging is a radiation-free clinical diagnostic tool that uses biocompatible contrast agents to enhance ultrasound signal, in order to improve image clarity and diagnostic performance. Ultrasound enhancing agents (UEA), which are usually gas microbubbles, are administered intravenously either by bolus injection or continuous infusion. UEA increase the accuracy and reliability of echocardiography, leading to changes in treatment, improving patient outcomes and lowering overall health care costs. In this review we describe: (1) the current clinical applications of ultrasound enhancing agents in echocardiography, with a brief review of the evidence underlying each of these applications; (2) emerging diagnostic and therapeutic applications of microbubble enhanced echocardiography (MEE), which rely either on the specific properties and composition of ultrasound enhancing agents or on the technical advances of clinical ultrasound systems; and (3) safety of MEE.
- Published
- 2022
- Full Text
- View/download PDF
21. Clinical Course Long After Atrial Switch: A Novel Risk Score for Major Clinical Events
- Author
-
Odilia I. Woudstra, Tjitske E. Zandstra, Rosanne F. Vogel, Arie P. J. van Dijk, Hubert W. Vliegen, Philippine Kiès, Monique R. M. Jongbloed, Anastasia D. Egorova, Pieter A. F. M. Doevendans, Thelma C. Konings, Barbara J. M. Mulder, Michael W. T. Tanck, Folkert J. Meijboom, and Berto J. Bouma
- Subjects
adult ,atrial switch ,Mustard repair ,prediction model ,Senning repair ,transposition of the great arteries ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background Patients with transposition of the great arteries corrected by an atrial switch operation experience major clinical events during adulthood, mainly heart failure (HF) and arrhythmias, but data on the emerging risks remain scarce. We assessed the risk for events during the clinical course in adulthood, and provided a novel risk score for event‐free survival. Methods and Results This multicenter study observed 167 patients with transposition of the great arteries corrected by an atrial switch operation (61% Mustard procedure; age, 28 [interquartile range, 24–36] years) for 13 (interquartile range, 9–16) years, during which 16 (10%) patients died, 33 (20%) had HF events, defined as HF hospitalizations, heart transplantation, ventricular assist device implantation, or HF‐related death, and 15 (9%) had symptomatic ventricular arrhythmias. Five‐year risk of mortality, first HF event, and first ventricular arrhythmia increased from 1% each at age 25 years, to 6% (95% CI, 4%–9%), 23% (95% CI, 17%–28%), and 5% (95% CI, 2%–8%), respectively, at age 50 years. Predictors for event‐free survival were examined to construct a prediction model using bootstrapping techniques. A prediction model combining age >30 years, prior ventricular arrhythmia, age >1 year at repair, moderate or greater right ventricular dysfunction, severe tricuspid regurgitation, and mild or greater left ventricular dysfunction discriminated well between patients at low (20%) 5‐year risk (optimism‐corrected C‐statistic, 0.86 [95% CI, 0.82–0.90]). Observed 5‐ and 10‐year event‐free survival rates in low‐risk patients were 100% and 97%, respectively, compared with only 31% and 8%, respectively, in high‐risk patients. Conclusions The clinical course of patients undergoing atrial switch increasingly consists of major clinical events, especially HF. A novel risk score stratifying patients as low, intermediate, and high risk for event‐free survival provides information on absolute individual risks, which may support decisions for pharmacological and interventional management.
- Published
- 2021
- Full Text
- View/download PDF
22. A regulatory circuit of two lncRNAs and a master regulator directs cell fate in yeast
- Author
-
Fabien Moretto, N. Ezgi Wood, Gavin Kelly, Andreas Doncic, and Folkert J. van Werven
- Subjects
Science - Abstract
Transcription of lncRNAs is known to regulate local gene expression. Here the authors describe how orchestrated transcription of two contiguous lncRNAs facilitates a regulatory circuit by which the master regulator for entry into meiosis, IME1, directs the decision to enter meiosis in yeast.
- Published
- 2018
- Full Text
- View/download PDF
23. Tricuspid flow and regurgitation in congenital heart disease and pulmonary hypertension: comparison of 4D flow cardiovascular magnetic resonance and echocardiography
- Author
-
Mieke M. P. Driessen, Marjolijn A. Schings, Gertjan Tj Sieswerda, Pieter A. Doevendans, Erik H. Hulzebos, Marco C. Post, Repke J. Snijder, Jos J. M. Westenberg, Arie P. J. van Dijk, Folkert J. Meijboom, and Tim Leiner
- Subjects
Tricuspid regurgitation ,4D-flow MRI ,Echocardiography ,Congenital heart disease ,Pulmonary hypertension ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background Tricuspid valve (TV) regurgitation (TR) is a common complication of pulmonary hypertension and right-sided congenital heart disease, associated with increased morbidity and mortality. Estimation of TR severity by echocardiography and conventional cardiovasvular magnetic resonance (CMR) is not well validated and has high variability. 4D velocity-encoded (4D-flow) CMR was used to measure tricuspid flow in patients with complex right ventricular (RV) geometry and varying degrees of TR. The aims of the present study were: 1) to assess accuracy of 4D-flow CMR across the TV by comparing 4D-flow CMR derived TV effective flow to 2D-flow derived effective flow across the pulmonary valve (PV); 2) to assess TV 4D-flow CMR reproducibility, and 3) to compare TR grade by 4D-flow CMR to TR grade by echocardiography. Methods TR was assessed by both 4D-flow CMR and echocardiography in 21 healthy subjects (41.2 ± 10.5 yrs., female 7 (33%)) and 67 RV pressure-load patients (42.7 ± 17.0 yrs., female 32 (48%)). The CMR protocol included 4D-flow CMR measurement across the TV, 2D-flow measurement across the PV and conventional planimetric measurements. TR grading on echocardiographic images was performed based on the international recommendations. Bland-Altman analysis and intra-class correlation coefficients (ICC) were used to asses correlations and agreement. Results TV effective flow measured by 4D-flow CMR showed good correlation and agreement with PV effective flow measured by 2D-flow CMR with ICC = 0.899 (p
- Published
- 2018
- Full Text
- View/download PDF
24. How to Differentiate Benign from Malignant Adrenocortical Tumors?
- Author
-
Charlotte L. Viëtor, Sara G. Creemers, Folkert J. van Kemenade, Tessa M. van Ginhoven, Leo J. Hofland, and Richard A. Feelders
- Subjects
adrenal tumors ,adrenocortical carcinoma ,diagnostics ,molecular markers ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Adrenocortical carcinoma (ACC) is a rare cancer with a poor prognosis. Adrenal incidentalomas are, however, commonly identified in clinical practice. Discrimination between benign and malignant adrenal tumors is of great importance considering the large differences in clinical behavior requiring different strategies. Diagnosis of ACC starts with a thorough physical examination, biochemical evaluation, and imaging. Computed tomography is the first-level imaging modality in adrenal tumors, with tumor size and Hounsfield units being important features for determining malignancy. New developments include the use of urine metabolomics, also enabling discrimination of ACC from adenomas preoperatively. Postoperatively, the Weiss score is used for diagnosis of ACC, consisting of nine histopathological criteria. Due to known limitations as interobserver variability and lack of accuracy in borderline cases, much effort has been put into new tools to diagnose ACC. Novel developments vary from immunohistochemical markers and pathological scores, to markers at the level of DNA, methylome, chromosome, or microRNA. Molecular studies have provided insights into the most promising and most frequent alterations in ACC. The use of liquid biopsies for diagnosis of ACC is studied, although in a small number of patients, requiring further investigation. In this review, current diagnostic modalities and challenges in ACC will be addressed.
- Published
- 2021
- Full Text
- View/download PDF
25. Exploring Differentially Methylated Genes in Vulvar Squamous Cell Carcinoma
- Author
-
Shatavisha Dasgupta, Patricia C. Ewing-Graham, Sigrid M. A. Swagemakers, Thierry P. P. van den Bosch, Peggy N. Atmodimedjo, Michael M. P. J. Verbiest, Marit de Haan, Helena C. van Doorn, Peter J. van der Spek, Senada Koljenović, and Folkert J. van Kemenade
- Subjects
vulva ,vulvar neoplasms ,epigenomics ,DNA methylation ,differentially methylated genes ,DNA copy number variations ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
DNA methylation is the most widely studied mechanism of epigenetic modification, which can influence gene expression without alterations in DNA sequences. Aberrations in DNA methylation are known to play a role in carcinogenesis, and methylation profiling has enabled the identification of biomarkers of potential clinical interest for several cancers. For vulvar squamous cell carcinoma (VSCC), however, methylation profiling remains an under-studied area. We sought to identify differentially methylated genes (DMGs) in VSCC, by performing Infinium MethylationEPIC BeadChip (Illumina) array sequencing, on a set of primary VSCC (n = 18), and normal vulvar tissue from women with no history of vulvar (pre)malignancies (n = 6). Using a false-discovery rate of 0.05, beta-difference (Δβ) of ±0.5, and CpG-island probes as cut-offs, 199 DMGs (195 hyper-methylated, 4 hypo-methylated) were identified for VSCC. Most of the hyper-methylated genes were found to be involved in transcription regulator activity, indicating that disruption of this process plays a vital role in VSCC development. The majority of VSCCs harbored amplifications of chromosomes 3, 8, and 9. We identified a set of DMGs in this exploratory, hypothesis-generating study, which we hope will facilitate epigenetic profiling of VSCCs. Prognostic relevance of these DMGs deserves further exploration in larger cohorts of VSCC and its precursor lesions.
- Published
- 2021
- Full Text
- View/download PDF
26. Evaluation of Immunohistochemical Markers, CK17 and SOX2, as Adjuncts to p53 for the Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia (dVIN)
- Author
-
Shatavisha Dasgupta, Senada Koljenović, Thierry P. P. van den Bosch, Sigrid M. A. Swagemakers, Nick M. A. van der Hoeven, Ronald van Marion, Peter J. van der Spek, Helena C. van Doorn, Folkert J. van Kemenade, and Patricia C. Ewing-Graham
- Subjects
vulva ,keratin-17 ,SOX2 protein, human ,carcinoma-in-situ ,neoplasms, squamous cell neoplasm ,Medicine ,Pharmacy and materia medica ,RS1-441 - Abstract
Histological diagnosis of differentiated vulvar intraepithelial neoplasia (dVIN), the precursor of human papillomavirus (HPV)-independent vulvar squamous cell carcinoma (VSCC), can be challenging, as features of dVIN may mimic those of non-dysplastic dermatoses. To aid the diagnosis, p53-immunohistochemistry (IHC) is commonly used, and mutant expression patterns are used to support a histological diagnosis of dVIN. However, a proportion of dVIN can show wild-type p53-expression, which is characteristic of non-dysplastic dermatoses. Furthermore, recent research has identified a novel precursor of HPV-independent VSCC—the p53-wild-type differentiated exophytic vulvar intraepithelial lesion (de-VIL). Currently, there are no established diagnostic IHC-markers for p53-wild-type dVIN or de-VIL. We evaluated IHC-markers, cytokeratin 17 (CK17), and SRY-box 2 (SOX2), as diagnostic adjuncts for dVIN. For this, IHC-expression of CK17, SOX2, and p53 was studied in dVIN (n = 56), de-VIL (n = 8), and non-dysplastic vulvar tissues (n = 46). For CK17 and SOX2, the percentage of cells showing expression, and the intensity and distribution of expression were recorded. We also performed next generation targeted sequencing (NGTS) on a subset of dVIN (n = 8) and de-VIL (n = 8). With p53-IHC, 74% of dVIN showed mutant patterns and 26% showed wild-type expression. Median percentage of cells expressing CK17 or SOX2 was significantly higher in dVIN (p53-mutant or p53-wild-type) and de-VIL than in non-dysplastic tissues (p < 0.01). Diffuse, moderate-to-strong, full epithelial expression of CK17 or SOX2 was highly specific for dVIN and de-VIL. With NGTS, TP53 mutations were detected in both dVIN and de-VIL. We infer that immunohistochemical markers CK17 and SOX2, when used along with p53, may help support the histological diagnosis of dVIN.
- Published
- 2021
- Full Text
- View/download PDF
27. Validation of Real-time Transthoracic 3D echocardiography in Children with Congenital Heart Disease
- Author
-
Annemien E. van den Bosch, Derk-Jan Ten Harkel, Jackie S. McGhie, Jolien W. Roos-Hesselink, Ad J.J.C Bogers, Wim A. Helbing, and Folkert J. Meijboom
- Subjects
congenital heart disease ,real-time 3d echocardiography ,child health ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Aims Assessment of feasibility, accuracy and applicability in clinical practice of real-time three-dimensional echocardiography (RT-3DE) in children with congenital heart defects. Methods and results From September 2004 to June 2005, 100 consecutive children (57 infants, 43 children > 1 year of age), who were scheduled for corrective intracardiac surgery, were enrolled in this study. RT-3DE was performed with Philips Sonos 7500 echo-system and off-line analysis with TomTec Echoview© software. Quantitative and qualitative assessments of the region of interest were performed on the 3D reconstruction, comparing these results with the anatomic findings and measurements performed during intracardiac surgery. Acquisition of RT-3DE datasets was feasible in 92 of the 100 (92%) patients and acquisition time was 6 ± 3 minutes. The overall quantitative analyses showed an excellent correlation (r < 0.90) between RT-3De and surgery. Also the qualitative analyses were accurate compared with surgical findings, in all patients in which RT-3DE was feasible. Conclusion This study shows that RT-3DE can be used in the clinical practice for the assessment of intracardiac anatomy in children with congenital heart disease. The information derived from the 3D reconstructions can be taken into consideration in the preoperative planning and management regarding interventional or surgical therapy.
- Published
- 2017
- Full Text
- View/download PDF
28. Plant-derived pectin nanocoatings to prevent inflammatory cellular response of osteoblasts following Porphyromonas gingivalis infection
- Author
-
Meresta A, Folkert J, Gaber T, Miksch K, Buttgereit F, Detert J, Pischon N, and Gurzawska K
- Subjects
nanocoatings ,Rhamnogalacturonan-I ,Porphyromonas gingivalis ,osteoblasts ,inflammation. ,Medicine (General) ,R5-920 - Abstract
Anna Meresta,1 Justyna Folkert,1 Timo Gaber,2 Korneliusz Miksch,1 Frank Buttgereit,2 Jacqueline Detert,2 Nicole Pischon,3,* Katarzyna Gurzawska3,4,* 1Environmental Biotechnology Department, Faculty of Power and Environmental, Silesian University of Technology, Gliwice, Poland; 2Department of Rheumatology and Clinical Immunology, 3Department of Periodontology, Charité University Medicine, Berlin, Germany; 4Oral Surgery Department, The School of Dentistry, University of Birmingham, Birmingham, UK *These authors contributed equally to this work Background: Bioengineered plant-derived Rhamnogalacturonan-Is (RG-Is) from pectins are potential candidates for surface nanocoating of medical devices. It has recently been reported that RG-I nanocoatings may prevent bacterial infection and improve the biocompatibility of implants. The aim of the study was to evaluate in vitro impact of bioengineered RG-I nanocoatings on osteogenic capacity and proinflammatory cytokine response of murine osteoblasts following Porphyromonas gingivalis infection.Methods: Murine MC3T3-E1 osteoblasts and isolated primary calvarial osteoblasts from C57BL/6J (B6J osteoblasts) mice were infected with P. gingivalis and incubated on tissue culture polystyrene plates with or without nanocoatings of unmodified RG-Is isolated from potato pulps (PU) or dearabinanated RG-Is (PA). To investigate a behavior of infected osteoblasts cultured on RG-Is cell morphology, proliferation, metabolic activity, mineralization and osteogenic and pro-inflammatory gene expression were examined.Results: Following P. gingivalis infection, PA, but not PU, significantly promoted MC3T3-E1 and BJ6 osteoblasts proliferation, metabolic activity, and calcium deposition. Moreover, Il-1b, Il-6, TNF-α, and Rankl gene expressions were downregulated in cells cultured on PU and to a higher extent on PA as compared to the corresponding control, whereas Runx, Alpl, Col1a1, and Bglap gene expressions were upregulated vice versa.Conclusion: Our data clearly showed that pectin RG-Is nanocoating with high content of galactan (PA) reduces the osteoblastic response to P. gingivalis infection in vitro and may, therefore, reduce a risk of inflammation especially in immunocompromised patients with rheumatoid or periodontal disorders. Keywords: nanocoatings, Rhamnogalacturonan-I, Porphyromonas gingivalis, osteoblasts, inflammation
- Published
- 2017
29. Nanocoating with plant-derived pectins activates osteoblast response in vitro
- Author
-
Folkert J, Meresta A, Gaber T, Miksch K, Buttgereit F, Detert J, Pischon N, and Gurzawska K
- Subjects
nanocoatings ,osseointegration ,osteoblasts ,mineralization ,Rhamnogalacturonan-I ,Medicine (General) ,R5-920 - Abstract
J Folkert,1 A Meresta,1 T Gaber,2 K Miksch,1 F Buttgereit,2 J Detert,2 N Pischon,3,* K Gurzawska3,4,* 1Environmental Biotechnology Department, Faculty of Power and Environmental, Silesian University of Technology, Gliwice, Poland; 2Department of Rheumatology and Clinical Immunology, 3Department of Periodontology, Charité-Universitätsmedizin, Berlin, Germany; 4Department of Oral Surgery, The School of Dentistry, University of Birmingham, Birmingham, UK *These authors contributed equally to this work Abstract: A new strategy to improve osseointegration of implants is to stimulate adhesion of bone cells, bone matrix formation, and mineralization at the implant surface by modifying surface coating on the nanoscale level. Plant-derived pectins have been proposed as potential candidates for surface nanocoating of orthopedic and dental titanium implants due to 1) their osteogenic stimulation of osteoblasts to mineralize and 2) their ability to control pectin structural changes. The aim of this study was to evaluate in vitro the impact of the nanoscale plant-derived pectin Rhamnogalacturonan-I (RG-I) from potato on the osteogenic response of murine osteoblasts. RG-I from potato pulps was isolated, structurally modified, or left unmodified. Tissue culture plates were either coated with modified RG-I or unmodified RG-I or – as a control – left uncoated. The effect of nanocoating on mice osteoblast-like cells MC3T3-E1 and primary murine osteoblast with regard to proliferation, osteogenic response in terms of mineralization, and gene expression of Runt-related transcription factor 2 (Runx2), alkaline phosphate (Alpl), osteocalcin (Bglap), α-1 type I collagen (Col1a1), and receptor activator of NF-κB ligand (Rankl) were analyzed after 3, 7, 14, and 21 days, respectively. Nanocoating with pectin RG-Is increased proliferation and mineralization of MC3T3-E1 and primary osteoblast as compared to osteoblasts cultured without nanocoating. Moreover, osteogenic transcriptional response of osteoblasts was induced by nanocoating in terms of gene induction of Runx2, Alpl, Bglap, and Col1a1 in a time-dependent manner – of note – to the highest extent under the PA-coating condition. In contrast, Rankl expression was initially reduced by nanocoating in MC3T3-E1 or remained unaltered in primary osteoblast as compared to the uncoated controls. Our results showed that nanocoating of implants with modified RG-I beneficially 1) supports osteogenesis, 2) has the capacity to improve osseointegration of implants, and is therefore 3) a potential candidate for nanocoating of bone implants. Keywords: nanocoatings, osseointegration, osteoblasts, mineralization, Rhamnogalacturonan-I
- Published
- 2016
30. Temporal Expression of a Master Regulator Drives Synchronous Sporulation in Budding Yeast
- Author
-
Minghao Chia and Folkert J. van Werven
- Subjects
gametogenesis ,sporulation ,synchrony ,budding yeast ,DNA replication ,meiotic divisions ,IME1 ,IME4 ,temporal ,Genetics ,QH426-470 - Abstract
Yeast cells enter and undergo gametogenesis relatively asynchronously, making it technically challenging to perform stage-specific genomic and biochemical analyses. Cell-to-cell variation in the expression of the master regulator of entry into sporulation, IME1, has been implicated to be the underlying cause of asynchronous sporulation. Here, we find that timing of IME1 expression is of critical importance for inducing cells to undergo sporulation synchronously. When we force expression of IME1 from an inducible promoter in cells incubated in sporulation medium for 2 hr, the vast majority of cells exhibit synchrony during premeiotic DNA replication and meiotic divisions. Inducing IME1 expression too early or too late affects the synchrony of sporulation. Surprisingly, our approach for synchronous sporulation does not require growth in acetate-containing medium, but can be achieved in cells grown in rich medium until saturation. Our system requires solely IME1, because the expression of the N6-methyladenosine methyltransferase IME4, another key regulator of early sporulation, is controlled by IME1 itself. The approach described here can be combined easily with other stage-specific synchronization methods, and thereby applied to study specific stages of sporulation, or the complete sporulation program.
- Published
- 2016
- Full Text
- View/download PDF
31. Hospital implementation of minimally invasive autopsy: A prospective cohort study of clinical performance and costs.
- Author
-
Ivo M Wagensveld, M G Myriam Hunink, Piotr A Wielopolski, Folkert J van Kemenade, Gabriel P Krestin, Britt M Blokker, J Wolter Oosterhuis, and Annick C Weustink
- Subjects
Medicine ,Science - Abstract
ObjectivesAutopsy rates worldwide have dropped significantly over the last decades and imaging-based autopsies are increasingly used as an alternative to conventional autopsy. Our aim was to evaluate the clinical performance and cost of minimally invasive autopsy.MethodsThis study was part of a prospective cohort study evaluating a newly implemented minimally invasive autopsy consisting of MRI, CT, and biopsies. We calculated diagnostic yield and clinical utility-defined as the percentage successfully answered clinical questions-of minimally invasive autopsy. We performed minimally invasive autopsy in 46 deceased (30 men, 16 women; mean age 62.9±17.5, min-max: 18-91).ResultsNinety-six major diagnoses were found with the minimally invasive autopsy of which 47/96 (49.0%) were new diagnoses. CT found 65/96 (67.7%) major diagnoses and MRI found 82/96 (85.4%) major diagnoses. Eighty-four clinical questions were asked in all cases. Seventy-one (84.5%) of these questions could be answered with minimally invasive autopsy. CT successfully answered 34/84 (40.5%) clinical questions; in 23/84 (27.4%) without the need for biopsies, and in 11/84 (13.0%) a biopsy was required. MRI successfully answered 60/84 (71.4%) clinical questions, in 27/84 (32.1%) without the need for biopsies, and in 33/84 (39.8%) a biopsy was required. The mean cost of a minimally invasive autopsy was €1296 including brain biopsies and €1087 without brain biopsies. Mean cost of CT was €187 and of MRI €284.ConclusionsA minimally invasive autopsy, consisting of CT, MRI and CT-guided biopsies, performs well in answering clinical questions and detecting major diagnoses. However, the diagnostic yield and clinical utility were quite low for postmortem CT and MRI as standalone modalities.
- Published
- 2019
- Full Text
- View/download PDF
32. Author Correction: High-resolution analysis of cell-state transitions in yeast suggests widespread transcriptional tuning by alternative starts
- Author
-
Minghao Chia, Cai Li, Sueli Marques, Vicente Pelechano, Nicholas M. Luscombe, and Folkert J. van Werven
- Subjects
Biology (General) ,QH301-705.5 ,Genetics ,QH426-470 - Abstract
An amendment to this paper has been published and can be accessed via the original article.
- Published
- 2021
- Full Text
- View/download PDF
33. RV adaptation to increased afterload in congenital heart disease and pulmonary hypertension.
- Author
-
Mieke M P Driessen, Tim Leiner, Gertjan Tj Sieswerda, Arie P J van Dijk, Marco C Post, Mark K Friedberg, Luc Mertens, Pieter A Doevendans, Repke J Snijder, Erik H Hulzebos, and Folkert J Meijboom
- Subjects
Medicine ,Science - Abstract
BACKGROUND:The various conditions causing a chronic increase of RV pressure greatly differ in the occurrence of RV failure, and in clinical outcome. To get a better understanding of the differences in outcome, RV remodeling, longitudinal function, and transverse function are compared between patients with pulmonary stenosis (PS), those with a systemic RV and those with pulmonary hypertension (PH). MATERIALS AND METHODS:This cross-sectional study prospectively enrolled subjects for cardiac magnetic resonance imaging (CMR), functional echocardiography and cardiopulmonary exercise testing. The study included: controls (n = 37), patients with PS (n = 15), systemic RV (n = 19) and PH (n = 20). Statistical analysis was performed using Analysis of Variance (ANOVA) with posthoc Bonferroni. RESULTS:PS patients had smaller RV volumes with higher RV ejection fraction (61.1±9.6%; p
- Published
- 2018
- Full Text
- View/download PDF
34. COVID-19 in the Netherlands: lessons from a nationwide query of dutch autopsy, histology, and cytology pathological reports
- Author
-
Lopuhaä, Boaz, Voorham, Q. J. M., van Kemenade, Folkert J., and von der Thüsen, Jan H.
- Published
- 2024
- Full Text
- View/download PDF
35. Nutrient Control of Yeast Gametogenesis Is Mediated by TORC1, PKA and Energy Availability.
- Author
-
Hilla Weidberg, Fabien Moretto, Gianpiero Spedale, Angelika Amon, and Folkert J van Werven
- Subjects
Genetics ,QH426-470 - Abstract
Cell fate choices are tightly controlled by the interplay between intrinsic and extrinsic signals, and gene regulatory networks. In Saccharomyces cerevisiae, the decision to enter into gametogenesis or sporulation is dictated by mating type and nutrient availability. These signals regulate the expression of the master regulator of gametogenesis, IME1. Here we describe how nutrients control IME1 expression. We find that protein kinase A (PKA) and target of rapamycin complex I (TORC1) signalling mediate nutrient regulation of IME1 expression. Inhibiting both pathways is sufficient to induce IME1 expression and complete sporulation in nutrient-rich conditions. Our ability to induce sporulation under nutrient rich conditions allowed us to show that respiration and fermentation are interchangeable energy sources for IME1 transcription. Furthermore, we find that TORC1 can both promote and inhibit gametogenesis. Down-regulation of TORC1 is required to activate IME1. However, complete inactivation of TORC1 inhibits IME1 induction, indicating that an intermediate level of TORC1 signalling is required for entry into sporulation. Finally, we show that the transcriptional repressor Tup1 binds and represses the IME1 promoter when nutrients are ample, but is released from the IME1 promoter when both PKA and TORC1 are inhibited. Collectively our data demonstrate that nutrient control of entry into sporulation is mediated by a combination of energy availability, TORC1 and PKA activities that converge on the IME1 promoter.
- Published
- 2016
- Full Text
- View/download PDF
36. Increased Expression of the EZH2 Polycomb Group Gene in BMI-1-Positive Neoplastic Cells during Bronchial Carcinogenesis
- Author
-
Roderick H.J. Breuer, Peter J.F. Snijders, Egbert F. Smit, Thomas G. Sutedja, Richard G.A.B. Sewalt, Arie P. Otte, Folkert J. van Kemenade, Pieter E. Postmus, Chris J.L.M. Meijer, and Frank M. Raaphorst
- Subjects
Premalignant lesions ,BMI-1 ,EZH2 ,polycomb genes ,lung carcinoma ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Polycomb group (PcG) genes are responsible for maintenance of cellular identity and contribute to regulation of the cell cycle. Recent studies have identified several PcG genes as oncogenes, and a role for PcG proteins in human oncogenesis is suspected. We investigated the expression of BMI-1 and EZH2 PcG oncogenes in human bronchial squamous cell carcinomas (SCCs) and bronchial premalignant precursor lesions (PLs). Whereas normal bronchial epithelium was associated with widespread expression of BMI-1 in resting EZH2-negative cells, neoplastic cells in lung carcinomas displayed altered expression of both BMI-1 and EZH2. Two patterns of abnormal PcG expression were observed: increased expression of BMI-1 in dividing neoplastic cells of PLs and SCCs, and enhanced expression of EZH2 and Ki-67 in BMI-1-positive cells according to severity of the histopathologic stage. We propose that altered expression of BMI1 and EZH2 is an early event that precedes high rates of proliferation in lung cancer. Because PcG complexes are normally involved in the maintenance of cell characteristics, abnormal PcG expression may contribute to loss of cell identity.
- Published
- 2004
- Full Text
- View/download PDF
37. Towards successful implementation of artificial intelligence in skin cancer care: a qualitative study exploring the views of dermatologists and general practitioners
- Author
-
Sangers, Tobias E., Wakkee, Marlies, Moolenburgh, Folkert J., Nijsten, Tamar, and Lugtenberg, Marjolein
- Published
- 2023
- Full Text
- View/download PDF
38. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT)
- Author
-
Breekveldt, Emilie C. H., Toes-Zoutendijk, Esther, de Jonge, Lucie, Spaander, Manon C. W., Dekker, Evelien, van Kemenade, Folkert J., van Vuuren, Anneke J., Ramakers, Christian R. B., Nagtegaal, Iris D., van Leerdam, Monique E., and Lansdorp-Vogelaar, Iris
- Published
- 2023
- Full Text
- View/download PDF
39. Can echocardiographic findings predict falls in older persons?
- Author
-
Nathalie van der Velde, Bruno H Ch Stricker, Jos R T C Roelandt, Folkert J Ten Cate, and Tischa J M van der Cammen
- Subjects
Medicine ,Science - Abstract
BACKGROUND: The European and American guidelines state the need for echocardiography in patients with syncope. 50% of older adults with syncope present with a fall. Nonetheless, up to now no data have been published addressing echocardiographic abnormalities in older fallers. METHOD AND FINDINGS: In order to determine the association between echocardiographic abnormalities and falls in older adults, we performed a prospective cohort study, in which 215 new consecutive referrals (age 77.4, SD 6.0) of a geriatric outpatient clinic of a Dutch university hospital were included. During the previous year, 139 had experienced a fall. At baseline, all patients underwent routine two-dimensional and Doppler echocardiography. Falls were recorded during a three-month follow-up. Multivariate adjustment for confounders was performed with a Cox proportional hazards model. 55 patients (26%) fell at least once during follow-up. The adjusted hazard ratio of a fall during follow-up was 1.35 (95% CI, 1.08-1.71) for pulmonary hypertension, 1.66 (95% CI, 1.01 to 2.89) for mitral regurgitation, 2.41 (95% CI, 1.32 to 4.37) for tricuspid regurgitation and 1.76 (95% CI, 1.03 to 3.01) for pulmonary regurgitation. For aortic regurgitation the risk of a fall was also increased, but non-significantly (hazard ratio, 1.57 [95% CI, 0.85 to 2.92]). Trend analysis of the severity of the different regurgitations showed a significant relationship for mitral, tricuspid and pulmonary valve regurgitation and pulmonary hypertension. CONCLUSIONS: Echo (Doppler) cardiography can be useful in order to identify risk indicators for falling. Presence of pulmonary hypertension or regurgitation of mitral, tricuspid or pulmonary valves was associated with a higher fall risk. Our study indicates that the diagnostic work-up for falls in older adults might be improved by adding an echo (Doppler) cardiogram in selected groups.
- Published
- 2007
- Full Text
- View/download PDF
40. Safety and Outcome of High-Flow Nasal Oxygen Therapy Outside ICU Setting in Hypoxemic Patients With COVID-19*
- Author
-
Janssen, Matthijs L., Türk, Yasemin, Baart, Sara J., Hanselaar, Wessel, Aga, Yaar, van der Steen-Dieperink, Mariëlle, van der Wal, Folkert J., Versluijs, Vera J., Hoek, Rogier A.S., Endeman, Henrik, Boer, Dirk P., Hoiting, Oscar, Hoelters, Jürgen, Achterberg, Sefanja, Stads, Susanne, Heller-Baan, Roxane, Dubois, Alain V.F., Elderman, Jan H., Wils, Evert-Jan, Gajadin, Shailin, Cox, Laura, Grewal, Sanjeev, van Oosten, Julien, Vlasveld, Imro N., and Jacobs, Wouter
- Published
- 2024
- Full Text
- View/download PDF
41. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme
- Author
-
van de Schootbrugge-Vandermeer, Hilliene J., Lansdorp-Vogelaar, Iris, de Jonge, Lucie, van Vuuren, Anneke J., Dekker, Evelien, Spaander, Manon C.W., Ramakers, Christian R.B., Nagtegaal, Iris D., van Kemenade, Folkert J., van Leerdam, Monique E., and Toes-Zoutendijk, Esther
- Published
- 2023
- Full Text
- View/download PDF
42. Identification of over- and undertreatment in the Dutch national cervical cancer screening program: A data linkage study at the hospital level
- Author
-
Vink, Maarten D., Hofstra, Geeske, Koolman, Xander, Bekkers, Ruud L., Siebers, Albert G., van Kemenade, Folkert J., Böcker, Koen B., ten Hove, Michiel, and van der Hijden, Eric J.
- Published
- 2023
- Full Text
- View/download PDF
43. Common genetic variants improve risk stratification after the atrial switch operation for transposition of the great arteries
- Author
-
Woudstra, Odilia I., Skoric-Milosavljevic, Doris, Mulder, Barbara J.M., Meijboom, Folkert J., Post, Marco C., Jongbloed, Monique R.M., van Dijk, Arie P.J., van Melle, Joost P., Konings, Thelma C., Postma, Alex V., Bezzina, Connie R., Bouma, Berto J., and Tanck, Michael W.T.
- Published
- 2023
- Full Text
- View/download PDF
44. Advanced-stage CRC incidence patterns following the phased implementation of the CRC screening programme in the Netherlands
- Author
-
Breekveldt, Emilie C.H., Toes-Zoutendijk, Esther, Spaander, Manon C.W., van de Schootbrugge-Vandermeer, Hilliene J., van Vuuren, Anneke J., van Kemenade, Folkert J., Ramakers, Christian R.B., Dekker, Evelien, Nagtegaal, Iris D., van Leerdam, Monique E., and Lansdorp-Vogelaar, Iris
- Published
- 2023
- Full Text
- View/download PDF
45. Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies
- Author
-
Varol, Hilal, Ernst, Angela, Cristoferi, Iacopo, Arns, Wolfgang, Baan, Carla C., van Baardwijk, Myrthe, van den Bosch, Thierry, Eckhoff, Jennifer, Harth, Ana, Hesselink, Dennis A., van Kemenade, Folkert J., de Koning, Willem, Kurschat, Christine, Minnee, Robert C., Mustafa, Dana A. M., Reinders, Marlies E. J., Shahzad-Arshad, Shazia P., Snijders, Malou L. H., Stippel, Dirk, Stubbs, Andrew P., von der Thüsen, Jan, Wirths, Katharina, Becker, Jan U., and Clahsen-van Groningen, Marian C.
- Published
- 2022
- Full Text
- View/download PDF
46. Baffle Complications in Adults After Atrial Switch for Transposition of the Great Arteries
- Author
-
Woudstra, Odilia I., Alban, Fabienne T.E., Bijvoet, Geertruida P., de Bruin-Bon, Rianne H.A.C.M., Planken, R. Nils, Leiner, Tim, Boekholdt, S. Matthijs, Warmerdam, Evangeline G., Sieswerda, Gertjan T., Mulder, Barbara J.M., Bouma, Berto J., and Meijboom, Folkert J.
- Published
- 2022
- Full Text
- View/download PDF
47. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study
- Author
-
van Bergeijk, Jeroen, Wiersma, Tjerk, van Grevenstein, Wilhelmina, Frasa, Marieke, van Gestel, Linda, Meijer, Gerrit, Breekveldt, Emilie C H, Lansdorp-Vogelaar, Iris, Toes-Zoutendijk, Esther, Spaander, Manon C W, van Vuuren, Anneke J, van Kemenade, Folkert J, Ramakers, Christian R B, Dekker, Evelien, Nagtegaal, Iris D, Krul, Myrtle F, Kok, Niels F M, Kuhlmann, Koert F D, Vink, Geraldine R, van Leerdam, Monique E, and Elferink, Marloes A G
- Published
- 2022
- Full Text
- View/download PDF
48. The Dutch National TissueArchive Portal enables efficient, consistent, and transparent procurement of diagnostic tissue samples for scientific use
- Author
-
Verjans, Robin, Bruggink, Annette H., Kibbelaar, Robby, Bart, Jos, Debernardi, Aletta, Schaaij-Visser, Tieneke B. M., Willems, Stefan M., and Van Kemenade, Folkert J.
- Published
- 2021
- Full Text
- View/download PDF
49. Multimodality Imaging, Diagnostic Challenges and Proposed Diagnostic Algorithm for Noncompaction Cardiomyopathy
- Author
-
Soliman, Osama I., McGhie, Jackie, ten Cate, Folkert J., Paelinck, Bernard P., Caliskan, Kadir, Caliskan, Kadir, editor, Soliman, Osama I., editor, and ten Cate, Folkert J., editor
- Published
- 2019
- Full Text
- View/download PDF
50. Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC‐2): A randomised controlled trial
- Author
-
van de Sande, Anna J. M., primary, van Baars, Romy, additional, Koeneman, Margot M., additional, Gerestein, Cornelis G., additional, Kruse, Arnold‐Jan, additional, van Esch, Edith M. G., additional, de Vos van Steenwijk, Peggy J., additional, Muntinga, Caroline L. P., additional, Willemsen, Sten P., additional, van Doorn, Helena C., additional, van Kemenade, Folkert J., additional, and van Beekhuizen, Helene J., additional
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.